Clinical trial
A Clinical Study Evaluating the Use od Ursodeoxycholic Acid as Adjuvant Therapy in Type 2 Diabetes Mellitus
NCT05902468 is registered in ClinicalTrials.gov with Tanta University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Clinical Study Evaluating the Use od Ursodeoxycholic Acid as Adjuvant Therapy in Type 2 Diabetes Mellitus
- Lead sponsor
- Tanta University
- Phase
- Phase 2/3
- Overall status
- Unknown status
- Start date
- June 28, 2023
- Completion date
- November 28, 2024
- Enrollment
- 88 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.